Cannabigerol
- Generic Name
- Cannabigerol
- Drug Type
- Small Molecule
- Chemical Formula
- C21H32O2
- CAS Number
- 25654-31-3
- Unique Ingredient Identifier
- J1K406072N
- Background
A natural product found in Cannabis sativa and Helichrysum species.
The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder
Phase 2
Recruiting
- Conditions
- Attention-Deficit/Hyperactivity Disorder
- Interventions
- Other: Placebo
- First Posted Date
- 2023-11-03
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- University of Arkansas, Fayetteville
- Target Recruit Count
- 30
- Registration Number
- NCT06115603
- Locations
- 🇺🇸
University of Arkansas, Fayetteville, Arkansas, United States
Acute Effects of Cannabigerol
Phase 1
Completed
- Conditions
- Focus: To Examine Acute Effects of CBG on Anxiety, Stress, and Cognition
- Interventions
- Other: Placebo
- First Posted Date
- 2022-02-25
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Washington State University
- Target Recruit Count
- 34
- Registration Number
- NCT05257044
- Locations
- 🇺🇸
Washington State University, Pullman, Washington, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath